Mark R. Ziebell - 09 Oct 2022 Form 4 Insider Report for Avid Bioservices, Inc.

Role
V. P., General Counsel
Signature
/s/ Mark R. Ziebell
Issuer symbol
N/A
Transactions as of
09 Oct 2022
Net transactions value
$0
Form type
4
Filing time
11 Oct 2022, 20:28:28 UTC
Previous filing
12 Jul 2022
Next filing
03 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDMO Common Stock, $0.001 par value Options Exercise +697 +2% 36,015 09 Oct 2022 Direct F1
transaction CDMO Common Stock, $0.001 par value Options Exercise +1,260 +3.5% 37,275 09 Oct 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDMO Restricted Stock Units Options Exercise $0 -697 -1.5% $0.000000 45,906 09 Oct 2022 Common Stock 697 Direct F1, F2
transaction CDMO Restricted Stock Units Options Exercise $0 -1,260 -2.7% $0.000000 44,646 09 Oct 2022 Common Stock 1,260 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
F2 RSUs granted to the reporting person on July 9, 2021, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2021 and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
F3 RSUs granted to the reporting person on July 9, 2022, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2022 and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.